Fibrillation, Atrial Clinical Trial
Official title:
An International, Multicentre, Randomised, Open, Controlled, Two-parallel Group, Phase II Pilot Study to Evaluate the Efficacy and Safety of ARIXTRA™ for Anticoagulation of Patients With Atrial Fibrillation Undergoing Electric Cardioversion Following Transesophageal Echocardiography
The purpose of this study is to test whether Fondaparinux is effective and safe to prevent thromboembolic events (like for example strokes) and bleeding events in patients who undergo a normalisation of their heart rhythm disturbance. Fondaparinux will be compared with Heparin and tablets containing Vitamin-K-Antagonists (Phenprocoumon, Fluindione, or Warfarin).
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00244725 -
Odiparcil For The Prevention Of Venous Thromboembolism
|
Phase 2 | |
| Terminated |
NCT00437242 -
Odiparcil QT Definitive Study
|
Phase 1 | |
| Completed |
NCT00402363 -
Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation
|
Phase 3 | |
| Completed |
NCT00240643 -
Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke
|
Phase 2 | |
| Completed |
NCT00041496 -
Prevention Of Recurrence Of Atrial Fibrillation
|
Phase 2 | |
| Not yet recruiting |
NCT06200311 -
Atrial Fibrillation (AF) Ablation to Prevent Disease Progression of AF-induced Atrial Cardiomyopathy in Women and Men
|
N/A | |
| Withdrawn |
NCT03401931 -
Artificial Intelligence Use for the Detection of Atrial Fibrillation Drivers
|
||
| Completed |
NCT04537507 -
Atrial Fibrillation and Non-obstructive Coronary Lesions
|
||
| Completed |
NCT04761315 -
Detecting Atrial Fibrillation in Patients With an Embolic Stroke of Undetermined Source (From the DAF-ESUS Registry)
|